Is it known whether the active ingredients in Trelegy Ellipta pass into human breast milk?

It is unknown whether Trelegy Ellipta’s fluticasone furoate, umeclidinium, vilanterol or their metabolites pass into human breast milk, and a risk to newborns or infants cannot be excluded.